Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Thrombocytopenia and PF4[original query] |
---|
The homozygous FcgammaRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin-platelet factor 4 complexes. Blood 2004 Nov 104 (9): 2791-3. Gruel Yves, Pouplard Claire, Lasne Dominique, Magdelaine-Beuzelin Charlotte, Charroing Chloé, Watier Her |
Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms. Platelets 2012 Jul . Pamela S, Maria LA, Elena D, Giovanni M, Emanuele A, Silvia V, Carmen B, Andreas G, Fabrizio F |
Polymorphisms of protein tyrosine phosphatase CD148 influence Fc?RIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia. Blood 2012 Aug 120 (6): 1309-16. Rollin Jérôme, Pouplard Claire, Gratacap Marie-Pierre, Leroux Dorothée, May Marc-Antoine, Aupart Michel, Gouilleux-Gruart Valérie, Payrastre Bernard, Gruel Yv |
Interleukin-10 promoter microsatellite polymorphisms influence the immune response to heparin and the risk of heparin-induced thrombocytopenia. Thrombosis research 2012 Apr 129 (4): 465-9. Pouplard Claire, Cornillet-Lefebvre Pascale, Attaoua Redha, Leroux Dorothée, Lecocq-Lafon Carinne, Rollin Jérôme, Grigorescu Florin, Nguyen Philippe, Gruel Yv |
A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical record. Thrombosis and haemostasis 2015 Apr 113 (4): 772-81. Karnes Jason H, Cronin Robert M, Rollin Jerome, Teumer Alexander, Pouplard Claire, Shaffer Christian M, Blanquicett Carmelo, Bowton Erica A, Cowan James D, Mosley Jonathan D, Van Driest Sara L, Weeke Peter E, Wells Quinn S, Bakchoul Tamam, Denny Joshua C, Greinacher Andreas, Gruel Yves, Roden Dan |
Polymorphism of the Fc? Receptor II as a Possible Predisposing Factor for Heparin-Induced Thrombocytopenia. Clinical laboratory 2015 61 (8): 1027-32. Slavik Ludek, Svobodova Gabriela, Ulehlova Jana, Krcova Vera, Hlusi Antonin, Prochazkova Jana, Hutyra Mart |
Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia. Transfusion 2018 12 59 (3): 931-934. Irani Mehraboon, Siegal Eric, Jella Abhay, Aster Richard, Padmanabhan Ana |
Heterogeneity in neutrophil responses to immune complexes. Blood advances 2019 9 3 (19): 2778-2789. Duarte Madelaine, Kuchibhatla Maragatha, Khandelwal Sanjay, Arepally Gowthami M, Lee Grace |
Analysis of genetic and clinical risk factors of post-transplant thrombocytopenia in kidney allograft recipients. Transplant immunology 2019 4 55 101206. Choi Kyung Hee, Chang Youngil, Shah Tariq, Min David |
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia.
Blood advances 2022 May . Giles Jason B, Steiner Heidi E, Rollin Jerome, Shaffer Christian M, Momozawa Yukihide, Mushiroda Taisei, Inai Chihiro, Selleng Kathleen, Thiele Thomas, Pouplard Claire, Heddle Nancy M, Kubo Michiaki, Miller Elise C, Martinez Kiana L, Phillips Elizabeth J, Warkentin Theodore E, Gruel Yves, Greinacher Andreas, Roden Dan M, Karnes Jason |
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia.
Blood 2022 4 140 (3): 274-284. Karnes Jason H, Rollin Jerome, Giles Jason B, Martinez Kiana L, Steiner Heidi E, Shaffer Christian M, Momozawa Yukihide, Inai Chihiro, Bombin Andrei, Shi Mingjian, Mosley Jonathan D, Stanaway Ian, Selleng Kathleen, Thiele Thomas, Mushiroda Taisei, Pouplard Claire, Heddle Nancy M, Kubo Michiaki, Phillips Elizabeth J, Warkentin Theodore E, Gruel Yves, Greinacher Andreas, Roden Dan |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 18, 2024
- Content source: